CARE

NEUTRALEarnings

Carter Bankshares, Inc.

2026-07-13

Price

$31.60

-2.95%

This is the 2026-07-13 snapshot — the signals and analysis for CARE as of this single trading day.

View full CARE research hub →

Score4.5Watchlist

Signals2/8 DNA1/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume0.8xvs 20d avg

Analysis

A high-conviction price discovery setup is unfolding in CARE as the resolution of legacy balance sheet risks aligns with a powerful PERFECT_STACK and GOLDEN_CROSS technical configuration. The stock is demonstrating strong institutional absorption, shrugging off broader regional bank margin concerns following a recent analyst upgrade to 'Buy' and anticipation of a $35.8M pre-tax gain from an asset sale in the upcoming Q2 earnings. With the macro regime in a RISK_ON state that is aggressively ignoring geopolitical noise, the stable volatility backdrop provides the perfect environment for fundamentally derisked, idiosyncratic stories like CARE to break out.

Fired Signals

GOLDEN CROSSPERFECT STACKPANIC REVERSALDISTRIBUTION

Key Takeaways

Actionable Thesis: Legacy risks have been cleared via a massive Q1 nonperforming loan sale [1.2.1], positioning CARE for a fundamental rerating supported by a PERFECT_STACK technical setup.
Key Risk: Broader regional banking margin compression or unexpected delays in realizing the expected Q2 insurance unit sale gain.
What to Watch: Watch for a breakout above the $34.19 resistance level heading into the July 23 Q2 earnings report.

← Back to 2026-07-13 View Full CARE History →Yahoo Finance &nearr;